• Users Online: 137
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others


Current status of radiation countermeasures for acute radiation syndrome under advanced development

Singh Vijay K, Fatanmi Oluseyi O, Santiago Paola T, Simas Madison, Hanlon Briana K, Garcia Melissa, Wise Stephen Y

Year : 2018| Volume: 9| Issue : 1 | Page no: 13-27

   This article has been cited by
1 Are animal models a necessity for acute radiation syndrome drug discovery?
Dörthe Schaue,William H. McBride
Expert Opinion on Drug Discovery. 2019; : 1
[Pubmed]  [Google Scholar] [DOI]
2 Repurposing Drugs for Cancer Radiotherapy
Mohammad K. Khan,Tahseen H. Nasti,Zachary S. Buchwald,Ralph R. Weichselbaum,Stephen J. Kron
The Cancer Journal. 2019; 25(2): 106
[Pubmed]  [Google Scholar] [DOI]
3 Mechanism and therapeutic window of a genistein nanosuspension to protect against hematopoietic-acute radiation syndrome
Michael R Landauer,Adam J Harvey,Michael D Kaytor,Regina M Day
Journal of Radiation Research. 2019;
[Pubmed]  [Google Scholar] [DOI]
4 Trichostatin A, an epigenetic modifier, mitigates radiation-induced androphysiological anomalies and metabolite changes in mice as evident from NMR-based metabolomics
Teena Haritwal,Kiran Maan,Poonam Rana,Suhel Parvez,Ajay K. Singh,Subash Khushu,Paban K. Agrawala
International Journal of Radiation Biology. 2018; : 1
[Pubmed]  [Google Scholar] [DOI]


Read this article